Global Craniomaxillofacial (CMF) Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thoracic Fixation, Bone Graft Substitute, and MF Plate and Screw Fixation.By Material;
Metal, Bioabsorbable Material, and Ceramic.By Application;
Neurosurgery & ENT, Orthognathic & Dental Surgery, and Plastic Surgery.By End Users;
Hospitals, Surgeons, Cosmetic Surgeons, and Ambulatory Surgery Centers.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Craniomaxillofacial (CMF) Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Craniomaxillofacial (CMF) Devices Market was valued at USD 890.43 million. The size of this market is expected to increase to USD 1,509.30 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.
Craniomaxillofacial (CMF) devices are instruments, medical implants, and tools specifically designed to treat and reconstruct defects, injuries, and deformities in the craniofacial region. The craniofacial region comprises the skull, jaw, face, and associated structures. CMF devices are used for surgical procedures, such as orthognathic surgery, trauma reconstruction, facial cosmetic surgery, and corrective procedures for congenital anomalies.
These devices are made from biocompatible materials such as bioresorbable polymers, titanium, and ceramics to ensure compatibility with the body and promote healing. The devices include implants such as screws, plates, meshes, and bone grafts, providing stability and support during healing. Additionally, CMF devices may include specialized instruments and tools surgeons use during procedures.
The primary goal of CMF devices is to restore aesthetics, functionality, and structural integrity to the craniofacial region, allowing patients to regain their normal oral functions, facial appearance, and overall quality of life. These devices are developed through advanced manufacturing techniques and often incorporate innovative technologies, such as 3D printing and computer-aided design, that provide patient-specific solutions and optimize surgical outcomes.
Craniomaxillofacial devices are majorly used in the surgical procedures of trauma injuries and reconstruction of facial and skull/cranial disorders. The different types of product or systems used in craniomaxillofacial surgical procedures include MF plate and screw fixation system, cranial flap fixation system, CMF distraction system, temporomandibular joint replacement system, thoracic fixation system and bone graft substitute systems. However, high cost of craniomaxillofacial surgeries that incorporate these devices and lack of awareness in developing regions may negatively impact the adoption of craniomaxillofacial devices, thereby impacting the industry growth. Craniomaxillofacial surgery involves dealing with congenital and acquired deformities of skull that is much more complicated and difficult than other surgeries, and involves participation of neurosurgeons, plastic surgeons, etc. making the overall procedure quite expensive.
Global Craniomaxillofacial (CMF) Devices Market Recent Developments
-
In June 2022, The U.S. Food and Drug Administration (FDA) granted 510(k) approval to Ricoh USA, Inc. for its RICOH 3D, craniomaxillofacial (CMF), and orthopaedic patient-specific anatomic modelling.
-
In February 2022, CrossRoads Extremity Systems, a Tennessee-based foot and ankle company that offers a wide range of procedure-specific, sterile-packed implants and equipment systems approved for lower extremity applications, was bought by DePuy Synthes, a division of Johnson &Johnson.
-
In November 2021, as a new generation of power tool system for trauma and minor bone surgeries, DePuy Synthes introduced the UNIUM System. Additionally applicable to sports medicine, spine, and thoracic treatments is this method.
Segment Analysis
The global Craniomaxillofacial (CMF) Devices market exhibits a multifaceted landscape, segmented across various dimensions to cater to diverse medical needs and technological advancements. Beginning with product types, the market encompasses Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thoracic Fixation, Bone Graft Substitute, and MF Plate and Screw Fixation. Each product category serves distinct functions within craniofacial and maxillofacial surgeries, addressing issues ranging from trauma to congenital deformities. Furthermore, material composition plays a crucial role in product efficacy and patient outcomes, with options including Metal, Bioabsorbable Material, and Ceramic, each offering specific advantages such as biocompatibility or structural integrity. In terms of application, the market caters to Neurosurgery & ENT, Orthognathic & Dental Surgery, and Plastic Surgery, reflecting the broad spectrum of medical disciplines requiring CMF interventions. This segmentation underscores the versatility of CMF devices in addressing both functional and aesthetic concerns across diverse patient populations. Finally, end users span across Hospitals, Surgeons, Cosmetic Surgeons, and Ambulatory Surgery Centers, indicating the widespread adoption of CMF devices across various healthcare settings. Hospitals remain a pivotal hub for complex procedures, while ambulatory surgery centers offer convenience and efficiency for outpatient treatments. Surgeons, including specialists in neurosurgery, orthognathic surgery, and plastic surgery, are instrumental in driving demand and innovation within the CMF devices market. Cosmetic surgeons, with a focus on aesthetic enhancements, also contribute significantly to market growth. Overall, the segmentation of the global CMF devices market underscores its dynamic nature, catering to a wide array of medical needs and preferences while fostering innovation and technological advancements to enhance patient care and surgical outcomes.
Global Craniomaxillofacial (CMF) Devices Segment Analysis
In this report, the Global Craniomaxillofacial (CMF) Devices Market has been segmented by Product Type, Material, Application, End Users, and Geography.
Global Craniomaxillofacial (CMF) Devices Market, Segmentation By Product Type
The Global Craniomaxillofacial (CMF) Devices Market has been segmented by Product Type into Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thoracic Fixation, Bone Graft Substitute, and MF Plate and Screw Fixation.
Each category represents a distinct class of medical devices designed to address specific anatomical or pathological conditions within the craniofacial and maxillofacial regions, thereby facilitating effective treatment and rehabilitation strategies. Cranial Flap Fixation stands as a critical component within neurosurgical interventions, enabling the stabilization and reconstruction of cranial defects resulting from trauma, tumor resection, or congenital anomalies. These devices typically comprise plates, screws, and fixation systems engineered to secure cranial flaps in place, promoting optimal healing and neurological function restoration. CMF Distraction devices serve a pivotal role in orthognathic surgery and craniofacial reconstruction by facilitating controlled bone growth and expansion. Employing mechanical principles of distraction osteogenesis, these devices gradually elongate and remodel bone segments, correcting skeletal deformities, and enhancing facial symmetry and function over time. Temporomandibular Joint Replacement devices offer a lifeline for patients suffering from severe temporomandibular joint disorders or traumatic injuries, providing prosthetic solutions to restore mandibular mobility, occlusal harmony, and pain-free jaw function. These implants replicate the anatomical and physiological characteristics of the temporomandibular joint, ensuring optimal biomechanical performance and long-term durability. Thoracic Fixation devices play a crucial role in stabilizing and reinforcing the skeletal framework following traumatic injuries or surgical interventions involving the thoracic spine and ribcage. These devices encompass a variety of implants and fixation systems designed to support fractured ribs, sternum, or thoracolumbar vertebrae, promoting respiratory function and facilitating the healing process.
Bone Graft Substitute materials represent a boon for reconstructive surgery, offering biocompatible alternatives to autologous bone grafts for bone regeneration and defect repair. These materials, which include synthetic ceramics, bioresorbable polymers, and osteoconductive scaffolds, provide a versatile platform for promoting osteogenesis, angiogenesis, and tissue integration without the associated risks of donor site morbidity or immunogenic reactions. MF Plate and Screw Fixation systems serve as the cornerstone of CMF surgery, facilitating rigid fixation and stabilization of bone fragments and osteotomies during trauma reconstruction, orthognathic surgery, and craniofacial contouring procedures. These implants, available in a myriad of sizes and configurations, offer unparalleled versatility and reliability in achieving optimal anatomical alignment and functional outcomes.
Global Craniomaxillofacial (CMF) Devices Market, Segmentation By Material
The Global Craniomaxillofacial (CMF) Devices Market has been segmented by Material into Metal, Bioabsorbable Material, and Ceramic.
Metal-based CMF devices have long been a cornerstone in surgical interventions due to their excellent mechanical properties, including high strength, durability, and corrosion resistance. Titanium and its alloys, such as titanium-6 aluminum-4 vanadium (Ti6Al4V), are commonly used in CMF applications due to their biocompatibility and ability to integrate with surrounding bone tissue through osseointegration. Metal plates, screws, and meshes provide stable fixation and support for bone fragments during fracture repair or reconstruction procedures. Additionally, advancements in metallurgy have led to the development of shape-memory alloys, such as nitinol, which offer unique properties like superelasticity, enabling customized fitting and minimally invasive approaches in CMF surgeries. Bioabsorbable materials represent a significant innovation in CMF device technology, offering the advantage of gradual degradation and replacement by native tissue over time. Polymers such as poly-lactic acid (PLA), poly-glycolic acid (PGA), and their copolymers are commonly utilized due to their biocompatibility and predictable degradation profiles. Bioabsorbable plates, screws, and meshes provide temporary stability and support during the healing process, eliminating the need for secondary removal surgeries associated with metal implants. This feature is particularly advantageous in pediatric patients and in procedures where long-term implant presence may pose risks or interfere with imaging techniques. Moreover, bioabsorbable materials stimulate bone healing and remodeling, ultimately leading to restoration of natural bone architecture. Ceramic materials, such as hydroxyapatite and bioglass, offer unique advantages in CMF applications, primarily due to their excellent biocompatibility and similarity to natural bone mineral composition. These materials promote osteoconduction, facilitating the ingrowth of bone tissue into implant surfaces, thereby enhancing stability and long-term integration. Ceramic implants are radiolucent, enabling clear visualization of underlying bone structures in postoperative imaging, unlike metal implants that cause artifacts. Additionally, ceramics exhibit low thrombogenicity and minimal inflammatory response, reducing the risk of complications such as infection or foreign body reactions. However, ceramic devices may be more prone to fracture compared to metals, necessitating careful patient selection and surgical technique.
Global Craniomaxillofacial (CMF) Devices Market, Segmentation By Application
The Global Craniomaxillofacial (CMF) Devices Market has been segmented by Application into Neurosurgery & ENT, Orthognathic & Dental Surgery, and Plastic Surgery.
Neurosurgery & ENT applications encompass a broad range of craniofacial procedures, including treatment for traumatic injuries, tumors, congenital defects, and diseases affecting the skull, brain, and associated structures such as the ears, nose, and throat. Within this segment, CMF devices play a crucial role in providing stabilization, reconstruction, and support to damaged or diseased craniofacial structures, facilitating optimal surgical outcomes and patient recovery. Additionally, the incorporation of advanced technologies such as patient-specific implants and navigation systems further enhances precision and efficacy in neurosurgical and ENT interventions. Orthognathic & Dental Surgery represents another significant application segment within the CMF devices market, addressing conditions related to jaw alignment, malocclusion, temporomandibular joint disorders, and dental deformities. CMF devices utilized in orthognathic surgery include plates, screws, distractors, and bone graft substitutes, which aid in repositioning the jaws, correcting bite discrepancies, and enhancing facial aesthetics and function. The demand for CMF devices in orthognathic and dental surgery is driven by the growing prevalence of craniofacial anomalies, increasing awareness of corrective procedures, and advancements in surgical techniques and materials, thereby fostering improved treatment outcomes and patient satisfaction.
Plastic Surgery constitutes a vital application segment within the CMF devices market, encompassing aesthetic and reconstructive procedures aimed at enhancing facial appearance, restoring facial symmetry, and addressing congenital anomalies, trauma-related injuries, and age-related changes. CMF devices play a pivotal role in procedures such as facial contouring, rhinoplasty, otoplasty, and facial rejuvenation, providing surgeons with tools for precise manipulation and augmentation of craniofacial tissues. The integration of biocompatible materials, tissue engineering technologies, and minimally invasive approaches has revolutionized the field of craniofacial plastic surgery, offering patients safer, more natural-looking outcomes with reduced recovery times and complications.
Global Craniomaxillofacial (CMF) Devices Market, Segmentation By End Users
The Global Craniomaxillofacial (CMF) Devices Market has been segmented by End Users into Hospitals, Surgeons, Cosmetic Surgeons, and Ambulatory Surgery Centers.
Hospitals stand as the cornerstone of CMF device utilization, serving as primary centers for comprehensive medical care, including emergency trauma cases and complex surgeries. Within hospital settings, specialized departments such as neurosurgery, oral and maxillofacial surgery, and plastic surgery are equipped with state-of-the-art facilities and expertise to address a wide spectrum of CMF disorders, ranging from traumatic injuries to congenital anomalies. Surgeons, comprising neurosurgeons, oral and maxillofacial surgeons, and plastic surgeons, constitute another critical segment of end users. These highly trained specialists possess the skills and expertise required to perform intricate CMF procedures, utilizing advanced techniques and innovative devices to achieve optimal patient outcomes. Their role extends beyond surgical intervention to encompass preoperative assessment, postoperative care, and ongoing management of CMF conditions. In addition to traditional hospital settings, the Global CMF Devices Market caters to the needs of ambulatory surgery centers (ASCs), which offer a convenient and cost-effective alternative for certain CMF procedures. ASCs specialize in outpatient surgeries, providing a streamlined approach to care delivery with reduced waiting times and enhanced patient satisfaction. These facilities are particularly well-suited for minor CMF surgeries, such as dental implants, facial fractures, and temporomandibular joint procedures, where same-day discharge and minimal recovery periods are feasible. Ambulatory surgery centers leverage advancements in anesthesia techniques, minimally invasive procedures, and patient monitoring technologies to ensure safe and efficient CMF interventions in a comfortable outpatient setting.
Moreover, cosmetic surgeons play a significant role in shaping the landscape of the CMF Devices Market, focusing on aesthetic enhancements and reconstructive procedures aimed at improving facial symmetry, contour, and appearance. With an emphasis on patient satisfaction and aesthetic outcomes, cosmetic surgeons utilize a range of CMF devices, including implants, fillers, and surgical instruments, to address cosmetic concerns such as facial aging, volume loss, and asymmetry. Their expertise extends beyond traditional medical interventions to encompass non-invasive treatments and minimally invasive procedures, catering to a growing demand for cosmetic enhancements and facial rejuvenation techniques.
Global Craniomaxillofacial (CMF) Devices Market, Segmentation by Geography
In this report, the Global Craniomaxillofacial (CMF) Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Craniomaxillofacial (CMF) Devices Market Share (%), by Geographical Region, 2024
North America dominated the global Craniomaxillofacial Devices market. The region has a well-established healthcare infrastructure, advanced technological capabilities, and high healthcare expenditure. Factors such as a higher prevalence of facial fractures, increasing demand for advanced surgical procedures, and a rising geriatric population contribute to the dominance of this segment. Additionally, favorable reimbursement policies, a strong presence of key market players, and extensive research and development activities further propel the market in North America.
Asia Pacific is the fastest growing segment in the global Craniomaxillofacial Devices market. The region is witnessing significant growth due to improving healthcare infrastructure, rising disposable income, increasing awareness about advanced treatment options, and a large patient pool. Countries such as China and India are driving the growth in this segment, supported by factors such as a rising geriatric population, growing investments in healthcare, and government initiatives to enhance healthcare facilities. Additionally, advancements in technology, increasing adoption of innovative surgical techniques, and a growing focus on medical tourism further contribute to the rapid growth of the Craniomaxillofacial Devices market in the Asia Pacific region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Craniomaxillofacial (CMF) Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Incidence of Trauma
- Rising Demand for Aesthetic Procedures
-
Increasing Awareness and Education- Heightened awareness about craniofacial and maxillofacial conditions among healthcare professionals and the general public is essential for early detection, diagnosis, and timely intervention. By promoting education initiatives, medical societies, advocacy groups, and healthcare organizations aim to enhance understanding of CMF disorders, their causes, symptoms, and available treatment options. This increased awareness leads to improved patient outcomes through early intervention, reduced morbidity, and better management of CMF conditions. Moreover, as awareness grows, there is a corresponding increase in demand for advanced CMF devices and surgical techniques. Patients and healthcare providers seek out cutting-edge solutions that offer superior outcomes, reduced invasiveness, and shorter recovery times. This demand stimulates innovation within the CMF Devices Market, prompting manufacturers to develop novel products and technologies that address unmet clinical needs and improve patient care.
Additionally, education plays a crucial role in empowering healthcare professionals with the knowledge and skills required to effectively utilize CMF devices and perform complex surgical procedures. Continuing medical education (CME) programs, training workshops, and hands-on courses provide surgeons, dentists, and allied healthcare professionals with opportunities to enhance their proficiency in CMF surgery, stay abreast of latest advancements, and adopt best practices. Furthermore, increasing awareness about the importance of facial aesthetics and its impact on quality of life has fueled demand for cosmetic CMF procedures. Educational campaigns highlighting the benefits of reconstructive surgery, facial rejuvenation techniques, and aesthetic enhancements contribute to a growing acceptance of cosmetic CMF interventions among patients and healthcare providers alike.
Restraints
- Stringent Regulatory Requirements
- Limited Reimbursement Policies
-
Surgical Risks and Complications- Despite advancements in surgical techniques and device technology, procedures involving the craniofacial and maxillofacial regions carry inherent risks that can lead to complications both during and after surgery. These risks can include infection, bleeding, nerve damage, tissue necrosis, and implant failure, among others. One of the primary concerns associated with CMF surgeries is the potential for postoperative complications, which can result in prolonged hospital stays, additional surgical interventions, and increased healthcare costs. For instance, infections at the surgical site pose a considerable risk, particularly in procedures involving the placement of implants or prosthetic devices. Infections can lead to delayed wound healing, tissue damage, and systemic complications, necessitating prompt intervention with antibiotics or surgical debridement.
The complex anatomy of the craniofacial region presents challenges in surgical access and manipulation, increasing the risk of intraoperative complications such as damage to surrounding structures, including nerves, blood vessels, and adjacent tissues. Nerve injury, in particular, can result in sensory or motor deficits, affecting patient function and quality of life postoperatively. Additionally, the use of fixation devices such as plates and screws carries the risk of malpositioning, loosening, or fracture, which may necessitate revision surgery or device removal. Moreover, patient-specific factors such as underlying medical conditions, anatomical variations, and comorbidities can further contribute to surgical risks and complications in CMF procedures. Patients with preexisting systemic diseases, such as diabetes or autoimmune disorders, may be at increased risk for complications such as impaired wound healing or infection. Additionally, anatomical variations or previous surgeries in the craniofacial region can complicate surgical planning and execution, potentially increasing the likelihood of adverse outcomes.
Opportunities
- Technological Advancements
- Expanding Applications in Emerging Markets
-
Increasing Preference for Minimally Invasive Procedures- Minimally invasive techniques involve smaller incisions, reduced tissue disruption, and shorter recovery times compared to traditional open surgeries, offering numerous benefits for both patients and healthcare providers. In the context of CMF procedures, the adoption of minimally invasive approaches is driven by several factors. Firstly, patients often prefer minimally invasive techniques due to the associated advantages, including less postoperative pain, minimal scarring, and faster return to normal activities. As a result, there is a growing demand for CMF devices that support minimally invasive approaches, such as specialized instrumentation, implants, and imaging technologies designed to facilitate precise and less invasive surgical interventions. From a healthcare provider perspective, minimally invasive procedures offer several advantages that contribute to improved patient outcomes and operational efficiency. By reducing tissue trauma and minimizing surgical complications, these techniques can lead to shorter hospital stays, decreased healthcare costs, and lower rates of postoperative complications, such as infections and wound healing issues. Additionally, minimally invasive approaches often result in improved cosmesis and patient satisfaction, further enhancing the overall quality of care.
The adoption of minimally invasive techniques in CMF surgery also opens up opportunities for innovation and technological advancement within the CMF Devices Market. Manufacturers are investing in the development of novel devices and technologies tailored specifically for minimally invasive procedures, including specialized endoscopic instruments, navigation systems, and robotic-assisted surgical platforms. These advancements aim to further enhance the precision, safety, and efficacy of minimally invasive CMF procedures while expanding the range of conditions that can be effectively treated using these techniques. Furthermore, the shift towards minimally invasive procedures aligns with broader trends in healthcare towards value-based care and patient-centered approaches. Healthcare systems worldwide are increasingly focused on delivering high-quality care while minimizing costs and improving patient satisfaction. Minimally invasive CMF procedures offer a means to achieve these objectives by reducing healthcare resource utilization, optimizing clinical outcomes, and enhancing the overall patient experience.
Competitive Landscape Analysis
Key players in Global Craniomaxillofacial (CMF) Devices Market include:
- Abbott Laboratories
- Alvimedica
- B. Braun Melsungen AG
- Biosensors International Group, Ltd.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cook Medical Inc.
- Elixir Medical Corporation
- Hexacath
- InspireMD Inc.
- Johnson & Johnson
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Stentys SA
- Terumo Corporation
- Translumina GmbH
- Vascular Concepts
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Material
- Market Snapshot, By Application
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Global Craniomaxillofacial (CMF) Devices/Systems Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Incidence of Trauma
-
Rising Demand for Aesthetic Procedures
-
Increasing Awareness and Education
-
- Restraints
-
Stringent Regulatory Requirements
-
Limited Reimbursement Policies
-
Surgical Risks and Complications
-
- Opportunities
-
Technological Advancements
-
Expanding Applications in Emerging Markets
-
Increasing Preference for Minimally Invasive Procedures
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Craniomaxillofacial (CMF) Devices/Systems Market, By Product Type, 2021 - 2031 (USD Million)
- Cranial Flap Fixation
- CMF Distraction
- Temporomandibular Joint Replacement
- Thoracic Fixation
- Bone Graft Substitute
- MF Plate
- Screw Fixation
- Global Craniomaxillofacial (CMF) Devices/Systems Market, By Material, 2021 - 2031 (USD Million)
- Metal
- Bioabsorbable Material
- Ceramic
- Global Craniomaxillofacial (CMF) Devices/Systems Market, By Application, 2021 - 2031 (USD Million)
- Neurosurgery & ENT
- Orthognathic & Dental Surgery
- Plastic Surgery
-
Global Craniomaxillofacial (CMF) Devices/Systems Market, By End Users, 2021 - 2031 (USD Million)
-
Hospitals
-
Surgeons
-
Cosmetic Surgeons
-
Ambulatory Surgery Centers
-
- Global Craniomaxillofacial (CMF) Devices/Systems Market, By Geography, 2021 - 2031 (USD Million)
-
North America
-
United States
-
Canada
-
-
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Nordic
-
Benelux
-
Rest of Europe
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia & New Zealand
-
South Korea
-
ASEAN (Association of South East Asian Countries)
-
Rest of Asia Pacific
-
-
Middle East & Africa
-
GCC
-
Israel
-
South Africa
-
Rest of Middle East & Africa
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
-
-
- Global Craniomaxillofacial (CMF) Devices/Systems Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
-
Abbott Laboratories
-
Alvimedica
-
B. Braun Melsungen AG
-
Biosensors International Group, Ltd.
-
Biotronik SE & Co. KG
-
Boston Scientific Corporation
-
C. R. Bard, Inc.
-
Cook Medical Inc.
-
Elixir Medical Corporation
-
Hexacath
-
InspireMD Inc.
-
Johnson & Johnson
-
Medtronic plc
-
Meril Life Sciences Pvt. Ltd.
-
MicroPort Scientific Corporation
-
Stentys SA
-
Terumo Corporation
-
Translumina GmbH
-
Vascular Concepts
-
- Company Profiles
- Analyst Views
- Future Outlook of the Market